Literature DB >> 10551692

Endothelial and metabolic characteristics of patients with angina and angiographically normal coronary arteries: comparison with subjects with insulin resistance syndrome and normal controls.

P Piatti1, G Fragasso, L D Monti, A Caumo, C Van Phan, G Valsecchi, S Costa, E Fochesato, G Pozza, A E Pontiroli, S Chierchia.   

Abstract

OBJECTIVES: This study was performed to characterize the endothelial and metabolic alterations of patients with angina and angiographically normal coronary arteries ("cardiac" syndrome X [CSX]) compared with subjects with insulin resistance syndrome ("metabolic" syndrome X [MSX]) and normal controls.
BACKGROUND: Previous studies have found high endothelin-1 levels, impaired endothelium-dependent vasodilation and insulin resistance in patients with angina pectoris and angiographically normal coronary arteries. On the other hand, subjects with insulin resistance syndrome have shown high endothelin-1 levels.
METHODS: Thirty-five subjects were studied: 13 patients with angina pectoris and angiographically normal coronary arteries (CSX group); 9 subjects with insulin resistance syndrome (MSX group) and 13 normal controls. All subjects received an acute intravenous bolus of insulin (0.1 U/kg) combined with a euglycemic clamp and forearm indirect calorimetry. Endothelin-1 levels, nitrite/nitrate (NOx) levels, end products of nitric oxide metabolism, glucose infusion rates (index of insulin sensitivity) and their incremental areas (deltaAUCs [area under curves]) were measured during this period.
RESULTS: Basal endothelin-1 levels were higher in CSX and MSX groups than in normal controls (8.19 +/- 0.46 and 6.97 +/- 0.88 vs. 3.67 +/- 0.99 pg/ml; p < 0.01), while basal NOx levels were significantly higher in MSX group than in CSX and normal controls (36.5 +/- 4.0 vs. 24.2 +/- 3.3 and 26.8 +/- 3.2 mol/liter, p < 0.05). After insulin administration, the deltaAUCs of NOx (p < 0.05) were lower in CSX group than in MSX and normal controls, and the deltaAUCs of endothelin-1 were lower in group CSX than in normal controls. Glucose infusion rate was significantly lower in CSX and MSx groups than in normal controls (p < 0.01), suggesting that in both CSX and MSX groups insulin resistance is present. A positive correlation was found between the deltaAUCs of nitric oxide and the AUCs of glucose infusion rate.
CONCLUSIONS: Blunted nitric oxide and endothelin responsiveness to intravenously infused insulin is a typical feature of patients with angina pectoris and angiographically normal coronary arteries and may contribute to the microvascular dysfunction observed in these subjects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10551692     DOI: 10.1016/s0735-1097(99)00379-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  12 in total

1.  Ultrasound measurement of peripheral endothelial dysfunction in type 2 diabetic patients: correlation with risk factors.

Authors:  Marijan Bosevski; Ljubica Georgievska-Ismail
Journal:  Bosn J Basic Med Sci       Date:  2010-05       Impact factor: 3.363

2.  Endothelin-1 impairs glucose transporter trafficking via a membrane-based mechanism.

Authors:  Andrew B Strawbridge; Jeffrey S Elmendorf
Journal:  J Cell Biochem       Date:  2006-03-01       Impact factor: 4.429

3.  Evaluation of adiponectin and lipoprotein(a) levels in cardiac syndrome X.

Authors:  E Guler; G B Guler; F Kizilirmak; U Batgerel; G G Demir; H M Gunes; O Karaca; Ö Özcan; I Barutcu; M M Turkmen; A M Esen
Journal:  Herz       Date:  2015-02-14       Impact factor: 1.443

Review 4.  Coronary microvascular dysfunction in women: an overview of diagnostic strategies.

Authors:  Sujith Kuruvilla; Christopher M Kramer
Journal:  Expert Rev Cardiovasc Ther       Date:  2013-11

5.  Arterial dysfunction in syndrome X: results of arterial reactivity and pulse wave propagation tests.

Authors:  M Kidawa; M Krzeminska-Pakula; J Z Peruga; J D Kasprzak
Journal:  Heart       Date:  2003-04       Impact factor: 5.994

Review 6.  Insulin resistance as a contributor to myocardial ischaemia independent of obstructive coronary atheroma: a role for insulin sensitisation?

Authors:  S Jadhav; J Petrie; W Ferrell; S Cobbe; N Sattar
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

Review 7.  Nitric oxide signaling during myocardial angiogenesis.

Authors:  Takahisa Kondo; Koichi Kobayashi; Toyoaki Murohara
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

Review 8.  Sex differences in cardiovascular disease - Impact on care and outcomes.

Authors:  K H Humphries; M Izadnegahdar; T Sedlak; J Saw; N Johnston; K Schenck-Gustafsson; R U Shah; V Regitz-Zagrosek; J Grewal; V Vaccarino; J Wei; C N Bairey Merz
Journal:  Front Neuroendocrinol       Date:  2017-04-18       Impact factor: 8.333

9.  Serum ADMA concentration-- an independent factor determining FMD impairment in cardiac syndrome X.

Authors:  Maciej Haberka; Katarzyna Mizia-Stec; Zbigniew Gasior; Magdalena Mizia; Joanna Janowska; Michał Holecki; Barbara Zahorska-Markiewicz
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

Review 10.  New directions in the treatment of heart failure: targeting free fatty acid oxidation.

Authors:  Gabriele Fragasso; Roberto Spoladore; Giorgio Bassanelli; Amarild Cuko; Chiara Montano; Anna Salerno; Alberto Margonato
Journal:  Curr Heart Fail Rep       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.